US Broker Ratings

Vera Therapeutics, Inc. (VERA) Stock Analysis: Examining a 168% Upside Potential

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, is capturing investor attention with its promising pipeline in the healthcare sector. With a focus on transformative..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: A 58% Potential Upside Beckons Investors

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands as a compelling prospect for investors eyeing the healthcare sector, particularly within the biotechnology industry. With its focused commitment to..

Disc Medicine, Inc. (IRON) Stock Analysis: An 85% Upside Potential Amid Innovative Biotech Endeavors

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, is capturing investor attention with a robust pipeline targeting serious hematologic diseases. With a..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook with 18% Potential Upside

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a prominent player in the biotechnology realm, is drawing attention from investors with its promising potential upside of 18.06%. Operating out..

ImmunityBio, Inc. (IBRX) Stock Analysis: A Promising 331% Upside Potential in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a biotechnology company based in San Diego, California, is capturing the attention of investors with a significant potential upside of 331.82%. Operating..

Phreesia, Inc. (PHR) Stock Analysis: 11.18% Potential Upside with Strong Buy Consensus

Phreesia, Inc. (NYSE: PHR), a leading player in the Health Information Services industry, presents a compelling investment opportunity for those looking to capitalize on the healthcare..

Bausch Health Companies Inc. (BHC) Stock Analysis: Assessing the 6.36% Potential Upside

Bausch Health Companies Inc. (BHC), a Canadian-based entity operating within the healthcare sector, presents a complex yet intriguing investment opportunity for those interested in the drug..

Amphastar Pharmaceuticals, Inc. (AMPH) Investor Outlook: Exploring a 41% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specializes in developing and marketing generic and proprietary injectable, inhalation, and intranasal products. Headquartered..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A Biotech Gem with 178% Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing the attention of investors with a promising portfolio in the biotechnology sector. Specializing in developing innovative treatments for intractable..

GRAIL, Inc. (GRAL) Stock Analysis: A Cautious Outlook Amidst Mixed Signals

GRAIL, Inc. (NASDAQ: GRAL), a trailblazer in the healthcare sector specializing in diagnostics and research, has piqued the interest of investors with its innovative approach to..

AdaptHealth Corp. (AHCO) Stock Analysis: A 36.53% Potential Upside in the Medical Devices Sector

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, specifically within the medical devices industry, is drawing attention with its promising stock potential. Based..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 15% Potential Upside for Investors

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a prominent player in the healthcare sector, is drawing attention with its promising potential upside of 15.41%, according to current..

Sotera Health Company (SHC) Investor Outlook: Assessing a 30% Upside Potential

Sotera Health Company (NASDAQ: SHC) is a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $3.16..

Viridian Therapeutics (VRDN) Stock Analysis: Unveiling a 174% Potential Upside in the Biotech Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a burgeoning name in the biotechnology industry, is drawing significant attention from investors with its promising pipeline and impressive potential upside...

Liquidia Corporation (LQDA) Stock Analysis: Unpacking a Potential 143% Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Liquidia Corporation (NASDAQ: LQDA) presents a unique opportunity. Based out of Morrisville, North Carolina, this biopharmaceutical company..

Arcellx, Inc. (ACLX) Stock Analysis: Unpacking a Promising 68.77% Potential Upside

For investors with an eye on biotechnology innovations, Arcellx, Inc. (NASDAQ: ACLX) represents a fascinating opportunity within the healthcare sector. With its primary focus on developing..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 75% Upside Potential

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) has positioned itself as a key player in the healthcare sector, specifically within the medical devices industry. The company is..

Adaptive Biotechnologies (ADPT): Investor Outlook with a 25% Revenue Growth and Strong Buy Ratings

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a forefront player in the biotechnology sector, is generating significant investor interest with its robust revenue growth and promising analyst ratings...

Innoviva, Inc. (INVA) Stock Analysis: A Potential 173% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Innoviva, Inc. (NASDAQ: INVA) an intriguing prospect, particularly given its substantial potential upside of 173.77% based on..

Indivior PLC (INDV) Stock Analysis: 28.90% Potential Upside Ignites Investor Interest

Investors eyeing the healthcare sector might want to take a closer look at Indivior PLC (NASDAQ: INDV). With a notable potential upside of 28.90% based on..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds